This course has no confirmed dates in the future. Subscribe to be notified when it is offered.
About the course
Negotiating the health dimension of drug policies
The 2016 United Nations General Assembly Special Session (UNGASS) on the World Drug Problem set the tone for the drug policy reform debate, but moving forward, many fear that this tone will be lost. In this 3-day course we will explore questions such as: What should the new direction post-2019 be for the future UN governance of international drug policy? How can different actors contribute to a global process in order to ensure that drug policies improve rather than harm the health and welfare of people? What should the role of civil society and user networks be in the international debate on drug policies?
Gain insight into the key concepts and current issues related to the international drug control regime and its intersection with global public health
Analyse the role of the Geneva-based agencies and understand how the human rights and global mechanisms balance drug control policies
Inform and influence the design and the implementation of drugs policies nationally and internationally
Identify the different stakeholders of the current debate at the regional and international levels be it governments, civil society or others
Consider national measures that protect public health in conformity with the international drug regime
This three-day course is designed to increase the understanding of participants on the main intersections between drug policy, public health and human rights in global policy processes. It includes the following topics:
International Drug Control Regime and perspectives for reform
Drug control, public health and human rights
Drug policy stakeholders and perspectives
The course is highly participatory, drawing on the national and international experiences of participants through a multi-disciplinary learning process. It includes lectures by internationally-renowned experts and negotiators, case studies, and working groups. A negotiation simulation exercise will complement the learning experience.
Who should attend
Policy-makers involved in public health, drug policy, and human rights negotiations including:
Government representatives from presidential offices, ministries of health, foreign affairs, justice, interior and drug control agencies
Representatives from international and regional institutions
Health attachés and diplomats with a portfolio linked to health or drug policy
Professionals in academia
Representatives from non-governmental organisations
Trust the experts
Michel Kazatchkine has over 30 years of experience in the fight against AIDS as a leading physician, researcher, administrator, advocate, policy-maker, and diplomat. He attended medical school in Paris and has completed postdoctoral fellowships at St. Mary’s hospital in London and Harvard Medical...
Thomas Zeltner, former Director-General of the Swiss National Health Authority (1991-2009), has a long history as an innovative leader in public health. Currently, he is Deputy Chair of the University Council of the Medical University of Vienna (Austria), head of international affairs of the Swis...